SMARCA4 and non-small cell lung carcinoma: Expression of the BRG1 subunit is absent in 15–50% of human primary non-small-cell lung cancer (NSCLC) samples, and mutations in BRG1 have been identified in 35% of NSCLC cell lines11–13.